ArticleBMC microbiology2025
A new approach for establishing multilocus sequence typing scheme: Staphylococcus capitis as an example.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
Abstract
Reliable and efficient typing methods for Staphylococcus capitis, an opportunistic pathogen of growing clinical and epidemiological concern, are urgently needed to support microbial epidemiological studies. In the study, we present a novel workflow for developing a multilocus sequence typing (MLST) scheme tailored to S. capitis. Core genome analysis of 603 high-quality S. capitis genomes revealed 2,065 core genes. A hierarchical filtering strategy, including gene, fragment, and combination filters, was applied to select loci that balance discriminatory power and cluster specificity. The final MLST scheme comprised fragments from seven genes: mntC, phoA, atpB_2, hisS, rluB, carB, and clpP. Using this approach, we assigned 39 sequence types (STs) and defined five clonal complexes. The MLST typing results were highly concordant with phylogenetic analysis and demonstrated considerable discriminatory power. Notably, the globally prevalent NRCS-A clone and the linezolid-resistant L clone were designated as ST1 and ST6, respectively. Overall, we developed a reliable, high-resolution MLST scheme for S. capitis that enables accurate characterization of its population structure and facilitates monitoring of multidrug-resistant lineages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.